8-[(2-Methylpyridin-3-yl)oxy]-4,5-dihydrothieno[3,4-g][1,2]benzisothiazole-6-carboxamide

ID: ALA4070408

PubChem CID: 126511887

Max Phase: Preclinical

Molecular Formula: C16H13N3O2S2

Molecular Weight: 343.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ncccc1Oc1sc(C(N)=O)c2c1-c1sncc1CC2

Standard InChI:  InChI=1S/C16H13N3O2S2/c1-8-11(3-2-6-18-8)21-16-12-10(14(22-16)15(17)20)5-4-9-7-19-23-13(9)12/h2-3,6-7H,4-5H2,1H3,(H2,17,20)

Standard InChI Key:  AIRVMUGRIFXGRE-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
    7.4380   -6.0796    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9795   -7.9464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6916   -8.3548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4037   -7.1213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4037   -7.9428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1849   -8.1968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6679   -7.5321    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.1850   -6.8676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2470   -5.9114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9795   -7.1214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6916   -6.7046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5153   -5.8987    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    4.6942   -5.8172    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.3632   -6.5729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4399   -8.9815    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8877   -9.5946    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2468   -9.1531    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7936   -6.5290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6019   -6.3613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8614   -5.5759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3065   -4.9580    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5002   -5.1288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9479   -4.5159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 10  2  1  0
  2  3  1  0
  3  5  1  0
  4 11  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  4  2  0
  8  1  1  0
  1  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
  6 15  1  0
 15 16  2  0
 15 17  1  0
  9 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22  9  1  0
 22 23  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4070408

    ---

Associated Targets(Human)

CDK19 Tchem Cyclin-C/Cyclin-dependent kinase 19 (323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK8 Tchem Cell division protein kinase 8 (1536 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK8 Tchem CDK8/Cyclin C (1054 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (3974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 343.43Molecular Weight (Monoisotopic): 343.0449AlogP: 3.56#Rotatable Bonds: 3
Polar Surface Area: 78.10Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.84CX Basic pKa: 5.47CX LogP: 2.49CX LogD: 2.49
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.79Np Likeness Score: -0.67

References

1. Ono K, Banno H, Okaniwa M, Hirayama T, Iwamura N, Hikichi Y, Murai S, Hasegawa M, Hasegawa Y, Yonemori K, Hata A, Aoyama K, Cary DR..  (2017)  Design and synthesis of selective CDK8/19 dual inhibitors: Discovery of 4,5-dihydrothieno[3',4':3,4]benzo[1,2-d]isothiazole derivatives.,  25  (8): [PMID:28302507] [10.1016/j.bmc.2017.02.038]

Source